Literature DB >> 19039255

Canada: public health genomics.

J Little1, B Potter, J Allanson, T Caulfield, J C Carroll, B Wilson.   

Abstract

Canada has a diverse population of 32 million people and a universal, publicly funded health care system provided through provincial and territorial health insurance plans. Public health activities are resourced at provincial/territorial level with strategic coordination from national bodies. Canada has one of the longest-standing genetics professional specialty organizations and is one of the few countries offering master's level training designed specifically for genetic counselors. Prenatal screening is offered as part of routine clinical prenatal services with variable uptake. Surveillance of the effect of prenatal screening and diagnosis on the birth prevalence of congenital anomalies is limited by gaps and variations in surveillance systems. Newborn screening programs vary between provinces and territories in terms of organization and conditions screened for. The last decade has witnessed a four-fold increase in requests for genetic testing, especially for late onset diseases. Tests are performed in provincial laboratories or outside Canada. There is wide variation in participation in laboratory quality assurance schemes, and there are few regulatory frameworks in Canada that are directly relevant to genetics testing services or population genetics. Health technology assessment in Canada is conducted by a diverse range of organizations, several of which have produced reports related to genetics. Several large-scale population cohort studies are underway or planned, with initiatives to harmonize their conduct and the management of ethical issues, both within Canada and with similar projects in other countries. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19039255     DOI: 10.1159/000156113

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  4 in total

1.  Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine.

Authors:  Katherine Bonter; Clarissa Desjardins; Nathan Currier; Jason Pun; Fredrick D Ashbury
Journal:  BMJ Open       Date:  2011-07-29       Impact factor: 2.692

2.  Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol.

Authors:  S G Nicholls; L Tessier; H Etchegary; J C Brehaut; B K Potter; R Z Hayeems; P Chakraborty; J Marcadier; J Milburn; D Pullman; L Turner; B J Wilson
Journal:  BMJ Open       Date:  2014-11-24       Impact factor: 2.692

3.  Identification of Delivery Models for the Provision of Predictive Genetic Testing in Europe: Protocol for a Multicentre Qualitative Study and a Systematic Review of the Literature.

Authors:  Brigid Unim; Tyra Lagerberg; Erica Pitini; Corrado De Vito; Maria Rosaria Vacchio; Giovanna Adamo; Annalisa Rosso; Elvira D'Andrea; Carolina Marzuillo; Paolo Villari
Journal:  Front Public Health       Date:  2017-08-22

4.  The Provision of Genetic Testing and Related Services in Quebec, Canada.

Authors:  Brigid Unim; Corrado De Vito; Julie Hagan; Paolo Villari; Bartha Maria Knoppers; Ma'n Zawati
Journal:  Front Genet       Date:  2020-03-04       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.